Two small Japanese banks made a fresh appeal on Monday, May 7, to be allowed to combine and pledged to ease antitrust concerns, as a battle between two government agencies that could shape the fate of the nation’s 100-plus struggling regional banks intensified.
Fukuoka Financial Group has been wanting to buy Eighteenth Bank in Nagasaki prefecture and merge it with one of its three lenders, Shinwa Bank. But the Japanese Fair Trade Commission (JFTC), Japan´s antitrust watchdog, has objected to the takeover since 2016 on the grounds that the merged entity would control about 70% of the lending market in Nagasaki, which it says would limit customers’ choices and could lead to higher lending rates.
The JFTC, which is still reviewing the case, is concerned the merger could create banks that are too dominant, undermine competition and lead to the closure of bank branches in remote areas.
Although Fukuoka Financial and Eighteenth Bank did not offer concrete steps to reduce their share of the lending market in a joint statement issued on Monday, they pledged the merged bank would not raise interest rates unfairly and maintain branches in depopulated areas.
“The merger of these two banks is the best choice for the financial support of economies in Nagasaki,” the banks announced in the statement, adding that deteriorating bank earnings would hurt the local economy.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas